GUD.TO
Knight Therapeutics Inc
Price:  
6.07 
CAD
Volume:  
58,814.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO Relative Valuation

-100.1%
Upside

As of 2024-05-23, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.07 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -100.1%.

The range of the Relative Valuation is (0.00) - (0.01) CAD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 0.0x - 0.1x 0.0x
Forward P/E multiples - -
Fair Price (0.00) - (0.01) (0.01)
Upside -100.1% - -100.2% -100.1%
6.07 CAD
Stock Price
(0.01) CAD
Fair Price

GUD.TO Relative Valuation - Historical P/E Data

Date P/E
2024-05-22 -36.06
2024-05-21 -36.48
2024-05-17 -36.72
2024-05-16 -36.90
2024-05-15 -36.66
2024-05-14 -36.96
2024-05-13 -36.36
2024-05-10 -35.70
2024-05-09 -36.66
2024-05-08 -35.58
2024-05-07 -35.28
2024-05-06 -35.58
2024-05-03 -35.52
2024-05-02 -34.98
2024-05-01 -34.67
2024-04-30 -34.67
2024-04-29 -34.80
2024-04-26 -34.43
2024-04-25 -34.19
2024-04-24 -34.37
2024-04-23 -34.98
2024-04-22 -34.80
2024-04-19 -34.37
2024-04-18 -34.80
2024-04-17 -35.22
2024-04-16 -34.67
2024-04-15 -34.61
2024-04-12 -34.25
2024-04-11 -35.28
2024-04-10 -34.98
2024-04-09 -33.47
2024-04-08 -33.29
2024-04-05 -32.57
2024-04-04 -31.97
2024-04-03 -32.09
2024-04-02 -31.61
2024-04-01 -31.97
2024-03-28 -31.85
2024-03-27 -32.69
2024-03-26 -32.63
2024-03-25 -31.55
2024-03-22 -31.67
2024-03-21 -31.43
2024-03-20 -32.39
2024-03-19 -32.45
2024-03-18 -32.33
2024-03-15 -31.85
2024-03-14 -31.97
2024-03-13 -31.73
2024-03-12 -31.91